Silence Therapeutics plc Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2023 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Silence Therapeutics plc quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2023 to Q2 2025.
  • Silence Therapeutics plc Retained Earnings (Accumulated Deficit) for the quarter ending June 30, 2025 was -$530M.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 -$530M Jun 30, 2025 10-Q 2025-08-07
Q1 2025 -$503M Mar 31, 2025 10-Q 2025-05-08
Q4 2024 -$474M -$42.2M -9.76% Dec 31, 2024 10-Q 2025-08-07
Q4 2023 -$432M Dec 31, 2023 10-K 2025-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.